Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis.
Trends Pharmacol Sci. 2020 Mar;41(3):199-208. doi: 10.1016/j.tips.2019.12.005. Epub 2020 Jan 21.
Trends Pharmacol Sci. 2020.
PMID: 31980251
Review.